OpGen

OPGN NASDAQ
0.3379
+0.0089
+2.71%
Closed 16:00 07/19 EDT
Open
0.3290
Prev Close
0.3290
High
0.3490
Low
0.3180
Volume
101.46K
Avg Vol (3M)
471.32K
52 Week High
2.410
52 Week Low
0.3160
% Turnover
0.58%
Market Cap
5.96M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers OpGen OPGN stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name.
MORE >

Recently

Name
Price
%Change